Advancing Mechanistic Understanding of Microbiome Therapeutics Through Pharmacokinetics & Engraftment Analysis to Demonstrate Clinical Credibility
- Examining mechanism of action data from microbiome therapeutic programs to build evidence-based narratives that strengthen regulatory and pharma partnership credibility
- Leveraging pharmacokinetic and engraftment data from clinical trials to deepen process understanding and demonstrate reproducible therapeutic activity in target indications
- Applying mechanistic insights from donor-derived and defined consortium programs to inform next-generation microbiome therapeutic development strategies